The work of researchers at CBAR has transformed HIV from a lethal disease into a manageable chronic condition, significantly lowering AIDS-related deaths by 69% since 2004.
CBAR plays a crucial role in HIV/AIDS research by providing leadership in the design and analysis of clinical trials, making significant contributions to the treatment and prevention of related diseases.
Our efforts extend beyond HIV, as we also lend our statistical expertise to address other prevalent diseases affecting individuals with HIV, enhancing global public health initiatives.
The legacy of CBAR is reflected in the longevity and dedication of its faculty and associates, who have been integral to HIV/AIDS research since the onset of the pandemic.
Collection
[
|
...
]